Cranbrook Wealth Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8K Hold
175
﹤0.01% 278
2026
Q1
$12.4K Hold
175
﹤0.01% 280
2025
Q4
$13.8K Hold
175
﹤0.01% 276
2025
Q3
$14.4K Hold
175
﹤0.01% 280
2025
Q2
$14.1K Hold
175
﹤0.01% 269
2025
Q1
$14.1K Hold
175
﹤0.01% 256
2024
Q4
$14.3K Hold
175
﹤0.01% 245
2024
Q3
$14.4K Hold
175
﹤0.01% 244
2024
Q2
$12.3K Hold
175
﹤0.01% 242
2024
Q1
$13K Hold
175
﹤0.01% 218
2023
Q4
$11.6K Hold
175
﹤0.01% 226
2023
Q3
$11K Hold
175
﹤0.01% 223
2023
Q2
$9.89K Buy
+175
New +$9.71K ﹤0.01% 227

Other funds holding MET

Cranbrook Wealth Management's MET Position: Q2 2026 in Review

Cranbrook Wealth Management held its MetLife (MET) position steady in Q2 2026 at 175 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #278.

Cranbrook Wealth Management first reported a position in MET in Q2 2023 and has held it in 13 quarters since. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Cranbrook Wealth Management held 175 shares of MetLife worth $14.8K as of Q2 2026.
  • Cranbrook Wealth Management left its MetLife share count unchanged in Q2 2026.
  • MetLife made up ﹤0.01% of Cranbrook Wealth Management's portfolio in Q2 2026, its #278 holding.
  • Cranbrook Wealth Management first reported a position in MetLife in Q2 2023 and has held it in 13 quarters since.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.